March 16, 2020 / 11:58 AM / 23 days ago

BRIEF-AGTC Announces Completion Of Enrollment In All Adult Dose Groups Of Its Ongoing Phase 1/2 Clinical Trials In Patients With Achromatopsia

March 16 (Reuters) - Applied Genetic Technologies Corp :

* AGTC ANNOUNCES COMPLETION OF ENROLLMENT IN ALL ADULT DOSE GROUPS OF ITS ONGOING PHASE 1/2 CLINICAL TRIALS IN PATIENTS WITH ACHROMATOPSIA

* APPLIED GENETIC TECHNOLOGIES CORP - INTERIM DATA OF ALL ADULT DOSE GROUPS EXPECTED IN 2H OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below